Oaklawn Dialysis Center Of Albion, Llc in Albion, Michigan - Dialysis Center

Oaklawn Dialysis Center Of Albion, Llc is a medicare approved dialysis facility center in Albion, Michigan and it has 16 dialysis stations. It is located in Calhoun county at 300 B Dr N, Albion, MI, 49224. You can reach out to the office of Oaklawn Dialysis Center Of Albion, Llc at (517) 654-1010. This dialysis clinic is managed and/or owned by Oaklawn Hospital. Oaklawn Dialysis Center Of Albion, Llc has the following ownership type - Profit. It was first certified by medicare in October, 2016. The medicare id for this facility is 232716 and it accepts patients under medicare ESRD program.

Dialysis Center Profile

NameOaklawn Dialysis Center Of Albion, Llc
Location300 B Dr N, Albion, Michigan
No. of Dialysis Stations 16
Medicare ID232716
Managed ByOaklawn Hospital
Ownership TypeProfit
Late Shifts No

Contact Information


300 B Dr N, Albion, Michigan, 49224
(517) 654-1010
Not Available

News Archive

Combination therapy produces clinical benefit for early stage non-small cell lung cancer

The first randomized Phase II clinical trial to report on single and combined neoadjuvant immune checkpoint inhibitor therapy in stage I-III non-small cell lung cancer (NSCLC) found combination therapy produced a significant clinical benefit, as assessed by major pathologic response (MPR) rate, as well as enhanced tumor immune cell infiltration and immunological memory.

New PHQ-9 screening test evaluates major depression in adults

Primary-care clinicians know teen depression is common, but they've lacked a reliable screening test for it. Now researchers at the University of Washington (UW), Seattle Children's, and Group Health report the PHQ-9 is a good screening test for major depression in adolescents.

Immunotherapy shows promise in treatment of Type 1 diabetes

Around 1.25 million Americans are living with type 1 diabetes and 40,000 new cases are detected each year. In this condition body's own immune system attacks and damages the insulin-producing β-cells inside the pancreas leading to impaired glucose metabolism in the body. There is no other treatment for this condition than regular painful insulin injections to maintain the normal insulin levels in the body. Type 1 diabetes is currently considered to be incurable.

Exerting more self control leads to negative emotions

People who make an effort to exert self-control are attracted to aggressive art and public policy appeals, according to a new study in the Journal of Consumer Research. They also don't appreciate messages that nag them to control their behavior.

Tofacitinib shows promise in active ulcerative colitis

Tofacitinib can induce a clinical response in the majority of patients with moderate to severe, active ulcerative colitis, a placebo-controlled trial has shown.

Read more Medical News

› Verified 9 days ago


Map and Direction



NPI Associated with this Dialysis Facility:

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with Oaklawn Dialysis Center Of Albion, Llc from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1336509660
Organization NameOaklawn Dialysis Center Of Albion, Llc
Doing Business AsOaklawn Dialysis Center Of Albion, Llc
Address350 North B Drive Albion, Michigan, 49224
Phone Number(517) 654-1010

News Archive

Combination therapy produces clinical benefit for early stage non-small cell lung cancer

The first randomized Phase II clinical trial to report on single and combined neoadjuvant immune checkpoint inhibitor therapy in stage I-III non-small cell lung cancer (NSCLC) found combination therapy produced a significant clinical benefit, as assessed by major pathologic response (MPR) rate, as well as enhanced tumor immune cell infiltration and immunological memory.

New PHQ-9 screening test evaluates major depression in adults

Primary-care clinicians know teen depression is common, but they've lacked a reliable screening test for it. Now researchers at the University of Washington (UW), Seattle Children's, and Group Health report the PHQ-9 is a good screening test for major depression in adolescents.

Immunotherapy shows promise in treatment of Type 1 diabetes

Around 1.25 million Americans are living with type 1 diabetes and 40,000 new cases are detected each year. In this condition body's own immune system attacks and damages the insulin-producing β-cells inside the pancreas leading to impaired glucose metabolism in the body. There is no other treatment for this condition than regular painful insulin injections to maintain the normal insulin levels in the body. Type 1 diabetes is currently considered to be incurable.

Exerting more self control leads to negative emotions

People who make an effort to exert self-control are attracted to aggressive art and public policy appeals, according to a new study in the Journal of Consumer Research. They also don't appreciate messages that nag them to control their behavior.

Tofacitinib shows promise in active ulcerative colitis

Tofacitinib can induce a clinical response in the majority of patients with moderate to severe, active ulcerative colitis, a placebo-controlled trial has shown.

Read more Medical News

› Verified 9 days ago


Patient Distribution

Anemia Management

Dialysis patients with Hemoglobin data12
Medicare patients who had average hemoglobin (hgb) less than 10 g/dL33

News Archive

Combination therapy produces clinical benefit for early stage non-small cell lung cancer

The first randomized Phase II clinical trial to report on single and combined neoadjuvant immune checkpoint inhibitor therapy in stage I-III non-small cell lung cancer (NSCLC) found combination therapy produced a significant clinical benefit, as assessed by major pathologic response (MPR) rate, as well as enhanced tumor immune cell infiltration and immunological memory.

New PHQ-9 screening test evaluates major depression in adults

Primary-care clinicians know teen depression is common, but they've lacked a reliable screening test for it. Now researchers at the University of Washington (UW), Seattle Children's, and Group Health report the PHQ-9 is a good screening test for major depression in adolescents.

Immunotherapy shows promise in treatment of Type 1 diabetes

Around 1.25 million Americans are living with type 1 diabetes and 40,000 new cases are detected each year. In this condition body's own immune system attacks and damages the insulin-producing β-cells inside the pancreas leading to impaired glucose metabolism in the body. There is no other treatment for this condition than regular painful insulin injections to maintain the normal insulin levels in the body. Type 1 diabetes is currently considered to be incurable.

Exerting more self control leads to negative emotions

People who make an effort to exert self-control are attracted to aggressive art and public policy appeals, according to a new study in the Journal of Consumer Research. They also don't appreciate messages that nag them to control their behavior.

Tofacitinib shows promise in active ulcerative colitis

Tofacitinib can induce a clinical response in the majority of patients with moderate to severe, active ulcerative colitis, a placebo-controlled trial has shown.

Read more Medical News

› Verified 9 days ago

Dialysis Adequacy

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

  • Hemodialysis
    Adult patients getting regular hemodialysis at the center32
    Adult patient months included in Kt/V greater than or equal to 1.2184
    Percentage of adult patients getting regular hemodialysis at the center99
    Percentage of pediatric patients getting regular hemodialysis at the center

    News Archive

    Combination therapy produces clinical benefit for early stage non-small cell lung cancer

    The first randomized Phase II clinical trial to report on single and combined neoadjuvant immune checkpoint inhibitor therapy in stage I-III non-small cell lung cancer (NSCLC) found combination therapy produced a significant clinical benefit, as assessed by major pathologic response (MPR) rate, as well as enhanced tumor immune cell infiltration and immunological memory.

    New PHQ-9 screening test evaluates major depression in adults

    Primary-care clinicians know teen depression is common, but they've lacked a reliable screening test for it. Now researchers at the University of Washington (UW), Seattle Children's, and Group Health report the PHQ-9 is a good screening test for major depression in adolescents.

    Immunotherapy shows promise in treatment of Type 1 diabetes

    Around 1.25 million Americans are living with type 1 diabetes and 40,000 new cases are detected each year. In this condition body's own immune system attacks and damages the insulin-producing β-cells inside the pancreas leading to impaired glucose metabolism in the body. There is no other treatment for this condition than regular painful insulin injections to maintain the normal insulin levels in the body. Type 1 diabetes is currently considered to be incurable.

    Exerting more self control leads to negative emotions

    People who make an effort to exert self-control are attracted to aggressive art and public policy appeals, according to a new study in the Journal of Consumer Research. They also don't appreciate messages that nag them to control their behavior.

    Tofacitinib shows promise in active ulcerative colitis

    Tofacitinib can induce a clinical response in the majority of patients with moderate to severe, active ulcerative colitis, a placebo-controlled trial has shown.

    Read more Medical News

    › Verified 9 days ago

  • Peritoneal Dialysis
    Adult patients getting regular peritoneal dialysis at the center5
    Adult patient months included in Kt/V greater than or equal to 1.732
    Percentage of adult patients getting regular peritoneal dialysis at the center
    Percentage of pediatric patients getting regular peritoneal dialysis at the center

    News Archive

    Combination therapy produces clinical benefit for early stage non-small cell lung cancer

    The first randomized Phase II clinical trial to report on single and combined neoadjuvant immune checkpoint inhibitor therapy in stage I-III non-small cell lung cancer (NSCLC) found combination therapy produced a significant clinical benefit, as assessed by major pathologic response (MPR) rate, as well as enhanced tumor immune cell infiltration and immunological memory.

    New PHQ-9 screening test evaluates major depression in adults

    Primary-care clinicians know teen depression is common, but they've lacked a reliable screening test for it. Now researchers at the University of Washington (UW), Seattle Children's, and Group Health report the PHQ-9 is a good screening test for major depression in adolescents.

    Immunotherapy shows promise in treatment of Type 1 diabetes

    Around 1.25 million Americans are living with type 1 diabetes and 40,000 new cases are detected each year. In this condition body's own immune system attacks and damages the insulin-producing β-cells inside the pancreas leading to impaired glucose metabolism in the body. There is no other treatment for this condition than regular painful insulin injections to maintain the normal insulin levels in the body. Type 1 diabetes is currently considered to be incurable.

    Exerting more self control leads to negative emotions

    People who make an effort to exert self-control are attracted to aggressive art and public policy appeals, according to a new study in the Journal of Consumer Research. They also don't appreciate messages that nag them to control their behavior.

    Tofacitinib shows promise in active ulcerative colitis

    Tofacitinib can induce a clinical response in the majority of patients with moderate to severe, active ulcerative colitis, a placebo-controlled trial has shown.

    Read more Medical News

    › Verified 9 days ago

Mineral and Bone Disorder

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Oaklawn Dialysis Center Of Albion, Llc with elevated calcium levels.

Patients with hypercalcemia36
Hypercalcemia patient months221
Hypercalcemia patients with serumcalcium greater than 10.2 mg1
Patients with Serumphosphor37
Patients with Serumphosphor less than 3.5 mg/dL4
Patients with Serumphosphor from 3.5 to 4.5 mg/dL18
Patients with Serumphosphor from 4.6 to 5.5 mg/dL31
Patients with Serumphosphor from 5.6 to 7 mg/dL31
Patients with Serumphosphor greater than 7 mg/dL16

News Archive

Combination therapy produces clinical benefit for early stage non-small cell lung cancer

The first randomized Phase II clinical trial to report on single and combined neoadjuvant immune checkpoint inhibitor therapy in stage I-III non-small cell lung cancer (NSCLC) found combination therapy produced a significant clinical benefit, as assessed by major pathologic response (MPR) rate, as well as enhanced tumor immune cell infiltration and immunological memory.

New PHQ-9 screening test evaluates major depression in adults

Primary-care clinicians know teen depression is common, but they've lacked a reliable screening test for it. Now researchers at the University of Washington (UW), Seattle Children's, and Group Health report the PHQ-9 is a good screening test for major depression in adolescents.

Immunotherapy shows promise in treatment of Type 1 diabetes

Around 1.25 million Americans are living with type 1 diabetes and 40,000 new cases are detected each year. In this condition body's own immune system attacks and damages the insulin-producing β-cells inside the pancreas leading to impaired glucose metabolism in the body. There is no other treatment for this condition than regular painful insulin injections to maintain the normal insulin levels in the body. Type 1 diabetes is currently considered to be incurable.

Exerting more self control leads to negative emotions

People who make an effort to exert self-control are attracted to aggressive art and public policy appeals, according to a new study in the Journal of Consumer Research. They also don't appreciate messages that nag them to control their behavior.

Tofacitinib shows promise in active ulcerative colitis

Tofacitinib can induce a clinical response in the majority of patients with moderate to severe, active ulcerative colitis, a placebo-controlled trial has shown.

Read more Medical News

› Verified 9 days ago

Vascular Access

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries 37
Patient months included in arterial venous fistula and catheter summaries 195
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment87
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer2

News Archive

Combination therapy produces clinical benefit for early stage non-small cell lung cancer

The first randomized Phase II clinical trial to report on single and combined neoadjuvant immune checkpoint inhibitor therapy in stage I-III non-small cell lung cancer (NSCLC) found combination therapy produced a significant clinical benefit, as assessed by major pathologic response (MPR) rate, as well as enhanced tumor immune cell infiltration and immunological memory.

New PHQ-9 screening test evaluates major depression in adults

Primary-care clinicians know teen depression is common, but they've lacked a reliable screening test for it. Now researchers at the University of Washington (UW), Seattle Children's, and Group Health report the PHQ-9 is a good screening test for major depression in adolescents.

Immunotherapy shows promise in treatment of Type 1 diabetes

Around 1.25 million Americans are living with type 1 diabetes and 40,000 new cases are detected each year. In this condition body's own immune system attacks and damages the insulin-producing β-cells inside the pancreas leading to impaired glucose metabolism in the body. There is no other treatment for this condition than regular painful insulin injections to maintain the normal insulin levels in the body. Type 1 diabetes is currently considered to be incurable.

Exerting more self control leads to negative emotions

People who make an effort to exert self-control are attracted to aggressive art and public policy appeals, according to a new study in the Journal of Consumer Research. They also don't appreciate messages that nag them to control their behavior.

Tofacitinib shows promise in active ulcerative colitis

Tofacitinib can induce a clinical response in the majority of patients with moderate to severe, active ulcerative colitis, a placebo-controlled trial has shown.

Read more Medical News

› Verified 9 days ago

Hospitalization Rate

The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.

Standard Hospitalization Summary Ratio(SHR) YearJanuary, 2016 - December, 2016
Patients in facility's Hospitalization Summary1
Hospitalization Rate in facility (Not Available)
Hospitalization Rate: Upper Confidence Limit
Hospitalization Rate: Lower Confidence Limit

News Archive

Combination therapy produces clinical benefit for early stage non-small cell lung cancer

The first randomized Phase II clinical trial to report on single and combined neoadjuvant immune checkpoint inhibitor therapy in stage I-III non-small cell lung cancer (NSCLC) found combination therapy produced a significant clinical benefit, as assessed by major pathologic response (MPR) rate, as well as enhanced tumor immune cell infiltration and immunological memory.

New PHQ-9 screening test evaluates major depression in adults

Primary-care clinicians know teen depression is common, but they've lacked a reliable screening test for it. Now researchers at the University of Washington (UW), Seattle Children's, and Group Health report the PHQ-9 is a good screening test for major depression in adolescents.

Immunotherapy shows promise in treatment of Type 1 diabetes

Around 1.25 million Americans are living with type 1 diabetes and 40,000 new cases are detected each year. In this condition body's own immune system attacks and damages the insulin-producing β-cells inside the pancreas leading to impaired glucose metabolism in the body. There is no other treatment for this condition than regular painful insulin injections to maintain the normal insulin levels in the body. Type 1 diabetes is currently considered to be incurable.

Exerting more self control leads to negative emotions

People who make an effort to exert self-control are attracted to aggressive art and public policy appeals, according to a new study in the Journal of Consumer Research. They also don't appreciate messages that nag them to control their behavior.

Tofacitinib shows promise in active ulcerative colitis

Tofacitinib can induce a clinical response in the majority of patients with moderate to severe, active ulcerative colitis, a placebo-controlled trial has shown.

Read more Medical News

› Verified 9 days ago